Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) Stock Ticker

NASDAQ: TMDX · Healthcare · Medical - Devices
$85.29+1.66%
USD · as of 2026-09-28 · market cap $2.9B
Open TMDX in TickrDownload for iPhone

TMDX right now

24% of the float is sold short.
Options expect by Oct 6±9.0%
Options expect by Oct 29±18.7%
Priced in for Nov 4 earnings±20.5%
IV rank (30-day)38% · fair
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full TMDX picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on TMDX
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About TransMedics Group, Inc.

TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.

TMDX stock facts

Ticker symbolTMDX
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryMedical - Devices
Market cap$2.9B
CEOWaleed H. Hassanein
Employees898
HeadquartersAndover, MA, US
IPO date2019-05-02
Websitewww.transmedics.com

What you can see for TMDX on Tickr

Live TMDX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TMDX report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for TransMedics Group, Inc.?

The ticker symbol for TransMedics Group, Inc. is TMDX, listed on the NASDAQ Global Market.

What is TMDX?

TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system…

HomeExploreMarketLists
All pages